Cargando…
Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers
Multiple sclerosis (MS) is an autoimmune disorder causing demyelination and neurodegeneration in the central nervous system. MS is characterized by disturbed motor performance and cognitive impairment. Current MS treatments delay disease progression and reduce relapse rates with general immunomodula...
Autores principales: | Verreycken, Janne, Baeten, Paulien, Broux, Bieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891682/ https://www.ncbi.nlm.nih.gov/pubmed/36576251 http://dx.doi.org/10.1080/21645515.2022.2153534 |
Ejemplares similares
-
Improving the Efficacy of Regulatory T Cell Therapy
por: Baeten, Paulien, et al.
Publicado: (2021) -
Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses
por: Yin, Qiliang, et al.
Publicado: (2022) -
Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer
por: Zhu, Yahui, et al.
Publicado: (2022) -
Current updates on generations, approvals, and clinical trials of CAR T-cell therapy
por: Asmamaw Dejenie, Tadesse, et al.
Publicado: (2022) -
Breaching Brain Barriers: B Cell Migration in Multiple Sclerosis
por: Rodriguez-Mogeda, Carla, et al.
Publicado: (2022)